Olivier Meyer

AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France.

Carlina Technologies SAS operates as a biopharmaceutical company. It specializes in the development of nanomedicines utilizing non-denaturing drug delivery technologies for therapeutic proteins, peptides and other types of drugs. The firm also provides formulation development and product development, process manufacturing, preclinical batch production, scale-up and technology transfer, analytical method development, and stability studies services. It serves the pharmaceutical, biotechnology, and veterinary industries. The company was founded by Olivier Meyer and Jean-Pierre Benoît in 2010 and is headquartered in Angers, France.

Bioxel Pharma, Inc. develops pharmaceutical products used in the treatment of cancer, multiple sclerosis and Alzheimers. The company is engaged in the development, production and distribution of therapeutically active taxanes isolated from the Canadian yew. Bioxel Pharma was founded on July 13, 1995 and is headquartered in Quebec, Canada.